With the UK’s default to leave the EU without a deal, there are a number of steps businesses in the life sciences sector should take to prepare. Many companies in the sector are faced with simultaneously navigating an increasingly complex regulatory environment while trying to mitigate as much as possible the significant impact of Brexit – including the effects of weak drug development pipelines, access to talent, supply chain disruption and potentially reduced research and development (R&D) funding.
Brexit Industry Insights$0.00 Deloitte
How the exponential growth of robotics,cognitive computing and other disruptive technologies impact the evolution of the
The Future of Operational Finance$0.00 Deloitte
SUPPLY chains traditionally are linear in nature, with a discrete progression of design, plan, source, make, and deliver. Today, however, many supply chains are transforming from a staid sequence to a dynamic, interconnected system that can more readily incorporate ecosystem partners and evolve to a more optimal state over time.
The rise of the digital supply network$0.00 Deloitte
Trouble with Conavigo
Want to refine your results?
Help with Sourcing
Need help with your Sourcing?